Literature DB >> 32929264

Artificial intelligence, drug repurposing and peer review.

Evelyne Bischof1,2,3, Alex Zhavoronkov4, Jeremy M Levin5,6, Tudor I Oprea7,8,9,10, Sagie Davidovich11, Thomas Clozel12, John P Overington13, Quentin Vanhaelen14, Charles R Cantor15.   

Abstract

Mesh：

Year:  2020        PMID： 32929264     DOI： 10.1038/s41587-020-0686-x

Source DB:  PubMed          Journal:  Nat Biotechnol        ISSN： 1087-0156            Impact factor:   54.908


× No keyword cloud information.
  2 in total

1.  [A pilot study of hydroxychloroquine in treatment of patients with moderate COVID-19].

Authors:  Jun Chen; Danping Liu; Li Liu; Ping Liu; Qingnian Xu; Lu Xia; Yun Ling; Dan Huang; Shuli Song; Dandan Zhang; Zhiping Qian; Tao Li; Yinzhong Shen; Hongzhou Lu
Journal:  Zhejiang Da Xue Xue Bao Yi Xue Ban       Date:  2020-05-25

2.  BioBERT: a pre-trained biomedical language representation model for biomedical text mining.

Authors:  Jinhyuk Lee; Wonjin Yoon; Sungdong Kim; Donghyeon Kim; Sunkyu Kim; Chan Ho So; Jaewoo Kang
Journal:  Bioinformatics       Date:  2020-02-15       Impact factor: 6.937
  2 in total
  15 in total

1.  Discovery of new drug indications for COVID-19: A drug repurposing approach.

Authors:  Priyanka Kumari; Bikram Pradhan; Maria Koromina; George P Patrinos; Kristel Van Steen
Journal:  PLoS One       Date:  2022-05-24       Impact factor: 3.752

2.  Machine learning enabled identification of potential SARS-CoV-2 3CLpro inhibitors based on fixed molecular fingerprints and Graph-CNN neural representations.

Authors:  Jacek Haneczok; Marcin Delijewski
Journal:  J Biomed Inform       Date:  2021-05-28       Impact factor: 8.000

3.  Overview of current state of research on the application of artificial intelligence techniques for COVID-19.

Authors:  Vijay Kumar; Dilbag Singh; Manjit Kaur; Robertas Damaševičius
Journal:  PeerJ Comput Sci       Date:  2021-05-26

4.  Virtual and In Vitro Antiviral Screening Revive Therapeutic Drugs for COVID-19.

Authors:  Giovanni Bocci; Steven B Bradfute; Chunyan Ye; Matthew J Garcia; Jyothi Parvathareddy; Walter Reichard; Surekha Surendranathan; Shruti Bansal; Cristian G Bologa; Douglas J Perkins; Colleen B Jonsson; Larry A Sklar; Tudor I Oprea
Journal:  ACS Pharmacol Transl Sci       Date:  2020-10-14

5.  AI drug discovery screening for COVID-19 reveals zafirlukast as a repurposing candidate.

Authors:  Marcin Delijewski; Jacek Haneczok
Journal:  Med Drug Discov       Date:  2020-12-24

Review 6.  Web resources facilitate drug discovery in treatment of COVID-19.

Authors:  Long-Can Mei; Yin Jin; Zheng Wang; Ge-Fei Hao; Guang-Fu Yang
Journal:  Drug Discov Today       Date:  2021-04-20       Impact factor: 7.851

Review 7.  Alkaloids in Contemporary Drug Discovery to Meet Global Disease Needs.

Authors:  Sharna-Kay Daley; Geoffrey A Cordell
Journal:  Molecules       Date:  2021-06-22       Impact factor: 4.411

Review 8.  Potential Therapeutic Targets and Vaccine Development for SARS-CoV-2/COVID-19 Pandemic Management: A Review on the Recent Update.

Authors:  Uttpal Anand; Shweta Jakhmola; Omkar Indari; Hem Chandra Jha; Zhe-Sheng Chen; Vijay Tripathi; José M Pérez de la Lastra
Journal:  Front Immunol       Date:  2021-06-30       Impact factor: 7.561

Review 9.  Open science approaches to COVID-19.

Authors:  Edwin G Tse; Dana M Klug; Matthew H Todd
Journal:  F1000Res       Date:  2020-08-25

10.  The Role of Artificial Intelligence in Fighting the COVID-19 Pandemic.

Authors:  Francesco Piccialli; Vincenzo Schiano di Cola; Fabio Giampaolo; Salvatore Cuomo
Journal:  Inf Syst Front       Date:  2021-04-26       Impact factor: 5.261
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.